Submitted by Anonymous (not verified) on 30 January 2024 - 16:17
Orphan designation: nicotinamide mononucleotide Treatment of sickle cell disease, 20/06/2023 Positive
Source:
Orphan designation: nicotinamide mononucleotide Treatment of sickle cell disease, 20/06/2023 Positive